Yoshimura Food Holdings K.K. Logo

Yoshimura Food Holdings K.K.

Acquires and revitalizes Japanese food SMEs via a support platform for global expansion.

2884 | T

Overview

Corporate Details

ISIN(s):
JP3958400008
LEI:
Country:
Japan
Address:
千代田区内幸町二丁目2番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Yoshimura Food Holdings K.K. is a holding company dedicated to preserving and growing Japan's food culture. Its core business is the merger and acquisition (M&A) of food-related small and medium-sized enterprises (SMEs) that possess high-quality products and unique manufacturing techniques but face business succession or growth challenges. The company operates a unique "SME support platform," providing comprehensive management assistance to its group companies in areas such as sales, marketing, and product development. This model focuses on long-term value creation and synergy, aiming to revitalize acquired businesses and expand the reach of their diverse food products to both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 09:06
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-10-15 09:05
Interim Report
半期報告書-第18期(2025/03/01-2026/02/28)
Japanese 207.9 KB
2025-06-02 07:08
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB
2025-05-30 07:25
Registration Form
確認書
Japanese 8.1 KB
2025-05-30 07:24
Governance Information
内部統制報告書-第17期(2024/03/01-2025/02/28)
Japanese 22.1 KB
2025-05-30 07:23
Annual Report
有価証券報告書-第17期(2024/03/01-2025/02/28)
Japanese 1.2 MB
2025-04-15 08:08
Management Discussion and Analysis
臨時報告書
Japanese 18.9 KB
2025-04-08 09:53
Capital/Financing Update
臨時報告書
Japanese 19.5 KB
2025-02-28 08:07
Capital/Financing Update
臨時報告書
Japanese 19.3 KB
2025-01-10 06:53
Regulatory News Service
臨時報告書
Japanese 18.5 KB
2024-12-09 08:34
Legal Proceedings Report
臨時報告書
Japanese 18.6 KB
2024-10-15 09:46
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-10-15 09:45
Interim Report
半期報告書-第17期(2024/03/01-2025/02/28)
Japanese 199.7 KB
2024-07-12 08:42
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-07-12 08:41
Quarterly Report
四半期報告書-第17期第1四半期(2024/03/01-2024/05/31)
Japanese 158.7 KB

Automate Your Workflow. Get a real-time feed of all Yoshimura Food Holdings K.K. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Yoshimura Food Holdings K.K.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Yoshimura Food Holdings K.K. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Tiziana Life Sciences Ltd Logo
Biotech firm developing immunotherapies for neurodegenerative diseases like MS and Alzheimer's.
United States of America
TLSA
TME Pharma N.V. Logo
Developing therapies for aggressive cancers by neutralizing the tumor microenvironment.
Germany
ALTME
TOKAI LEASE CO.,LTD. Logo
Manufactures and leases temporary buildings and fixtures for the construction sector.
Japan
9761
ToolGen Incorporated Logo
A biotech firm licensing genome editing patents for therapeutics and agriculture.
South Korea
199800
Trade Desk, Inc. Logo
A self-service platform for ad agencies & brands to manage data-driven digital ad campaigns.
United States of America
TTD
Trainers´ House Oyj Logo
Consulting & coaching firm driving growth via leadership, sales & strategy execution.
Finland
TRH1V
TRAJANO Logo
Provides strategic consulting and innovative business solutions.
Spain
YTRA
Transgene Logo
Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.
France
TNG
TRANS GENIC GROUP INC. Logo
Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.
Japan
2342
Trevi Therapeutics, Inc. Logo
Clinical-stage biopharma developing an oral therapy for chronic cough in IPF and RCC.
United States of America
TRVI

Talk to a Data Expert

Have a question? We'll get back to you promptly.